Research interests include Virus-based gene therapy research, Immunotherapy and Immune Responses, CAR-T cell therapy research, and RNA Interference and Gene Delivery.
Gene Therapy-Mediated Reprogramming Tumor Infiltrating T Cells Using IL-2 and Inhibiting NF-κB Signaling Improves the Efficacy of Immunotherapy in a Brain Cancer Model
Neurotherapeutics2012cited by 38position: middledoi